Related Experiment Video
Updated: May 4, 2026

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis
Kim A Staats1, Susann Schönefeldt2, Marike Van Rillaer2
1KU Leuven Laboratory of Neurobiology and Leuven Research Institute for Neuroscience and Disease (LIND) Leuven, Belgium ; VIB Vesalius Research Center, KU Leuven Leuven, Belgium ; VIB Autoimmune Genetics Laboratory, KU Leuven Leuven, Belgium ; Department of Microbiology and Immunology, University of Leuven Leuven, Belgium.
Abstract:
Beta-2 microglobulin (β2m) is an essential component of the major histocompatibility complex (MHC) class I proteins and in the nervous system β2m is predominantly expressed in motor neurons. As β2m can promote nerve regeneration, we investigated its potential role in amyotrophic lateral sclerosis (ALS) by investigating its expression level as well as the effect of genetically removing β2m on the disease process in mutant superoxide dismutase 1 (SOD1 (G93A) ) mice, a model of ALS. We observed a strong upregulation of β2m in motor neurons during the disease process and ubiquitous removal of β2m dramatically shortens the disease duration indicating that β2m plays an essential and positive role during the disease process. We hypothesize that β2m contributes to plasticity that is essential for muscle reinnervation. Absence of this plasticity will lead to faster muscle denervation and counteracting this process could be a relevant therapeutic target.
More Related Videos
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018